Search For "member health"
Second wave still not over, no one is safe until entire country is safe: D
Updated : 4 years, 11 months ago IST
New Delhi [India], July 2 (ANI): Niti Aayog member, health, Dr VK Paul on Friday cautioned that the second wave of COVID-19 is not over yet even though India is seeing a decline in the number of fresh cases.
Read More
No need to panic over change in gap between two Covishield doses: Dr VK Pa
Updated : 4 years, 11 months ago IST
New Delhi [India], June 11 (ANI): Member Health, NITI Aayog, Dr VK Paul on Friday assured that there is no need for panic over an immediate switchover or change in the gap between the doses of Covishield vaccine.
Read More
ICMR to start 4th national serosurvey in June, states should also assess C
Updated : 4 years, 11 months ago IST
New Delhi [India], June 11 (ANI): Member Health NITI Aayog Dr VK Paul on Friday announced that the Indian Council of Medical Research (ICMR) will start work on the next nation-wide Covid-19 serosurvey and urged states to roll out their own sero surveillances to asses the spread of the pan
Read More
Talks with Pfizer, Moderna for Covid-19 vaccines under consideration, No c
Updated : 4 years, 12 months ago IST
New Delhi [India], June 8 (ANI): Even as Pfizer's Covid vaccine has being authorised for use in children in the US and parts of Europe, Dr VK Paul, Member-Health at Niti Aayog said that approval to the coronavirus vaccines of Pfizer and Moderna is under consideration in India.
Read More
Manufacturers to decide price of COVID vaccines to pvt sectors, says Dr VK
Updated : 4 years, 12 months ago IST
New Delhi [India], June 8 (ANI): The price of COVID vaccines to private sectors (hospitals) will be decided by vaccine manufacturers, informed Member (health) NITI Aayog Dr VK Paul on Tuesday.
Read More
India overtakes US as 17.2 cr people receive first dose of COVID-19 vaccin
Updated : 5 years ago IST
New Delhi [India], June 4 (ANI): Member Health NITI Aayog Dr VK Paul on Friday said India has overtaken the United States in terms of the number of people who have received the first dose of COVID-19 vaccine.
Read More
Covid-19 infection not taken serious shape among children, can impact if c
Updated : 5 years ago IST
New Delhi [India], June 1 (ANI): Member (Health), NITI Aayog Dr VK Paul on Tuesday assured that COVID-19 infection has not taken a serious shape among children and added that the childhood COVID-19 disease is gaining their attention but warns of impacting the age group, if the virus changes
Read More
India needs to prepare to give one crore COVID-19 doses in a day, possible
Updated : 5 years ago IST
New Delhi [India], May 27 (ANI): India should prepare to give one crore COVID-19 jabs a day which will be possible in a few weeks with due preparation and the vaccination should be taken up to 73 doses in the next three weeks, Niti Aayog Member (Health) Dr VK Paul has said.
Read More
Dr VK Paul, member NITI Aayog, busts myths on India's vaccination process
Updated : 5 years ago IST
New Delhi [India], May 27 (ANI): Chair of the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) and Member (Health) in NiTi Aayog, Dr Vinod K Paul on Thursday addressed seven myths on India's Covid-19 vaccination program.
Read More
COVID-19 situation stabalising in major part of country, says Niti Aayog m
Updated : 5 years ago IST
New Delhi [India], May 22 (ANI): The situation created by COVID-19 "is stabilising in a major part of the country" with the positivity rate and active cases going down, VK Paul, Member (Health), Niti Aayog, said on Saturday.
Read More
Mixing of two different COVID vaccines is still being analysed: Niti Aayog
Updated : 5 years ago IST
New Delhi [India], May 21 (ANI): Taking two jabs of two different COVID vaccines is "theoretically possible", but more in-depth research is needed in the matter, Dr VK Paul, Member Health NITI aayog said on Saturday.
Read More
Covaxin phase II/III clinical trials for 2-18 age group to begin in 10-12
Updated : 5 years ago IST
New Delhi [India], May 18 (ANI): Bharat Biotech is set to begin the phase II and III clinical trials for COVID-19 vaccine Covaxin in children in the age group of 2 to 18 years in the next 10-12 days, informed VK Paul, Member (Health), Niti Aayog on Tuesday.
Read More